Figures & data
Table 1. Risk factors for opioid use disorder (Citation5–7).
Table 2. Signs of opioid overdose (Citation1, Citation29).
Table 3. Administration of opioid reversal agents (Citation32–35).
Table 4. Individuals who should have ready access to naloxone/nalmefene (Citation35, Citation37).
Table 5. Physiological manifestations of opioid withdrawal (Citation23, Citation29).
Table 9. Management of opioid use disorder: Methadone and naltrexone (Citation23, Citation29, Citation42, Citation43).
Table 6. Buprenorphine kinetics (Citation23, Citation29, Citation49–51).
Table 7. Buprenorphine dosing and administration (Citation23, Citation29, Citation42, Citation49, Citation50, Citation56).
Table 8. Buprenorphine-naloxone dosing & administration (Citation23, Citation29, Citation44, Citation45, Citation53, Citation56).